(1) Barbitone, or veronal (di-ethyl-barbituric acid), (2) sodium barbitone, or medinal (sodium salt of barbitone), (3) proponal (di-propyl-barbituric acid), (4) neonal, or soneryl (N. butyl-etliyl-barbituric acid), (5) dial (di-allyl-barbituric acid), (6) phenobarbitone, or luminal (di-phenyl-barbiturie acid), (7) sodium luminal, (8) phanodorn (cyclo-hexenyl-ethyl-barbituric acid), (9) evipan (N. methyl-cyclo-hexenyl-methylbarbituric acid), (10) sodium evipan, (11) pentobarbitone (ethyl-methyl-butyl-barbituric acid) and (12) its sodium salt, nembutal, (13) ipral (calcium ethyl iso-propyl-barbituric acid), (14) allonal (a combination of allyl-iso-propyl-barbituric acid with amidopyrin), (15) (23) amytal (iso-amyl-ethyl-barbiUiric acid) , (24) pernocton (2 butyl-brom-ethyl-barbituric acid), (the sodium salts of both these are used by the intravenous route to produce anaesthesia), (25) nastal (iso-propyl-bromallyl-barbituric acid), and (26) sandoptal (iso-butylallyl-barbituric acid) . The question of habit formation with these drugs has been discussed by Gillespie (1934) and he has brought forward certain a priori considerations against the likelihood of the frequent occurrence of this.
While engaged in the study of According to Gillespie (1934) 
